On February 6, 2024, A-shares continued to rise after opening slightly lower, and accelerated in the afternoon, and the major broad-based indices all ushered in a straight line up. Among the major broad-based indexes, the STAR 100 Index ETF (588030), which tracks the STAR 100, rose 758%, with an intraday turnover of more than 800 million yuan, and active trading. Among the constituent stocks, Borui Pharmaceutical, Haier Biotechnology, and Dizhe Pharmaceutical rose by more than 14%; Arctech and Huaqin Technology followed suit, up more than 12%.
On the news side, ** Huijin Company has recently fully recognized the value of the current A** field allocation, and has recently expanded the scope of exchange-traded open-end index ** (ETF) holdings, and will continue to increase its holdings, expand the scale of holdings, and resolutely maintain the smooth operation of the capital market.
Huatai ** believes that the current position of A-shares has investment cost performance, and short-term disturbances accumulate space for medium and long-term improvement: 1) Whether it is a horizontal comparison of stock and bond yields, a longitudinal calculation of the quantile of equity risk premium, or a calculation of the statistical law of historical calendar effects before and after the Spring Festival, it shows that A-shares are currently cost-effective and are expected to usher in a recovery after the holiday; 2) The lighting rate of the bottom signal system is more than 90%, indicating that the current position of A-shares is solid and ready to go; 3) The reform of the capital market continues to advance, and policies guide the steady entry of medium and long-term funds into the market, which will help enhance investor confidence; 4) China's economy is in a period of transition, the old momentum is stabilizing, and the accumulation of new momentum will improve the first structure.
The above content and data have nothing to do with the position of the interface and do not constitute investment advice. Do so at your own risk.